Fox-2 Protein Regulates the Alternative Splicing of Scleroderma-associated Lysyl Hydroxylase 2 Messenger RNA

Overview

Journal Arthritis Rheum

Specialty Rheumatology

Date 2010 Feb 5

PMID 20131247

Citations 10

Authors

Puneet Seth

Heather N Yeowell

Affiliations

Soon will be listed here.

Abstract

Objective: Scleroderma (systemic sclerosis [SSc]) is a complex connective tissue disorder characterized by hardening and thickening of the skin. One hallmark of scleroderma is excessive accumulation of collagen accompanied by increased levels of pyridinoline collagen crosslinks derived from hydroxylysine residues in the collagen telopeptide domains. Lysyl hydroxylase 2 (LH2), an important alternatively spliced enzyme in collagen biosynthesis, acts as a collagen telopeptide hydroxylase. Changes in the pattern of LH2 alternative splicing, favoring increased inclusion of the alternatively spliced LH2 exon 13A, thereby increasing the levels of the long transcript of LH2 (LH2[long]), are linked to scleroderma disease. This study was undertaken to examine the role played by RNA binding protein Fox-2 in regulating exon 13A inclusion, which leads to the generation of scleroderma-associated LH2(long) messenger RNA (mRNA).

Methods: Phylogenetic sequence analysis of introns flanking exon 13A was performed. A tetracycline-inducible system in T-Rex 293 cells was used to induce Fox-2 protein, and endogenous LH2(long) mRNA was determined by reverse transcriptase-polymerase chain reaction. An LH2 minigene was designed, validated, and used in Fox-2 overexpression and mutagenesis experiments. Knockdown of Fox-2 was performed in mouse embryonic fibroblasts and in fibroblasts from SSc patients.

Results: Overexpression of Fox-2 enhanced the inclusion of exon 13A and increased the generation of LH2(long) mRNA, whereas knockdown of Fox-2 decreased LH2(long) transcripts. Mutational analysis of an LH2 minigene demonstrated that 2 of the 4 Fox binding motifs flanking LH2 exon 13A are required for inclusion of exon 13A. In early passage fibroblasts derived from patients with scleroderma, the knockdown of Fox-2 protein significantly decreased the endogenous levels of LH2(long) mRNA.

Conclusion: Our findings indicate that Fox-2 plays an integral role in the regulation of LH2 splicing. Knockdown of Fox-2 and other methods to decrease the levels of fibrosis-associated LH2(long) mRNA in primary scleroderma cells may suggest a novel approach to strategies directed against scleroderma.

Citing Articles

Cellular and Molecular Effects of the Bruck Syndrome-Associated Mutation in the Gene.

Bolshakova O, Latypova E, Komissarov A, Slobodina A, Ryabova E, Varfolomeeva E Int J Mol Sci. 2025; 25(24.

PMID: 39769143 PMC: 11676324. DOI: 10.3390/ijms252413379.

RNA splicing factor RBFOX2 is a key factor in the progression of cancer and cardiomyopathy.

Shen J, Shentu J, Zhong C, Huang Q, Duan S Clin Transl Med. 2024; 14(9):e1788.

PMID: 39243148 PMC: 11380049. DOI: 10.1002/ctm2.1788.

Get Spliced: Uniting Alternative Splicing and Arthritis.

van Haaren M, Steller L, Vastert S, Calis J, van Loosdregt J Int J Mol Sci. 2024; 25(15).

PMID: 39125692 PMC: 11311815. DOI: 10.3390/ijms25158123.

Uterine Collagen Cross-Linking: Biology, Role in Disorders, and Therapeutic Implications.

Kurt I, Kulhan M, AlAshqar A, Borahay M Reprod Sci. 2023; 31(3):645-660.

PMID: 37907804 DOI: 10.1007/s43032-023-01386-7.

Overhydroxylation of Lysine of Collagen Increases Uterine Fibroids Proliferation: Roles of Lysyl Hydroxylases, Lysyl Oxidases, and Matrix Metalloproteinases.

Kamel M, Wagih M, Kilic G, Diaz-Arrastia C, Baraka M, Salama S Biomed Res Int. 2017; 2017:5316845.

PMID: 29082249 PMC: 5610812. DOI: 10.1155/2017/5316845.

References

Walker L, Overstreet M, Yeowell H . Tissue-specific expression and regulation of the alternatively-spliced forms of lysyl hydroxylase 2 (LH2) in human kidney cells and skin fibroblasts. Matrix Biol. 2005; 23(8):515-23. DOI: 10.1016/j.matbio.2004.11.002. View

Zhang C, Zhang Z, Castle J, Sun S, Johnson J, Krainer A . Defining the regulatory network of the tissue-specific splicing factors Fox-1 and Fox-2. Genes Dev. 2008; 22(18):2550-63. PMC: 2546699. DOI: 10.1101/gad.1703108. View

Kivirikko K, Myllyla R . Post-translational processing of procollagens. Ann N Y Acad Sci. 1985; 460:187-201. DOI: 10.1111/j.1749-6632.1985.tb51167.x. View

Underwood J, Boutz P, Dougherty J, Stoilov P, Black D . Homologues of the Caenorhabditis elegans Fox-1 protein are neuronal splicing regulators in mammals. Mol Cell Biol. 2005; 25(22):10005-16. PMC: 1280273. DOI: 10.1128/MCB.25.22.10005-10016.2005. View

Yeowell H, Walker L . Tissue specificity of a new splice form of the human lysyl hydroxylase 2 gene. Matrix Biol. 1999; 18(2):179-87. DOI: 10.1016/s0945-053x(99)00013-x. View

Baraniak A, Chen J, Garcia-Blanco M . Fox-2 mediates epithelial cell-specific fibroblast growth factor receptor 2 exon choice. Mol Cell Biol. 2006; 26(4):1209-22. PMC: 1367178. DOI: 10.1128/MCB.26.4.1209-1222.2006. View

Jin Y, Suzuki H, Maegawa S, Endo H, Sugano S, Hashimoto K . A vertebrate RNA-binding protein Fox-1 regulates tissue-specific splicing via the pentanucleotide GCAUG. EMBO J. 2003; 22(4):905-12. PMC: 145449. DOI: 10.1093/emboj/cdg089. View

Pornprasertsuk S, Duarte W, Mochida Y, Yamauchi M . Overexpression of lysyl hydroxylase-2b leads to defective collagen fibrillogenesis and matrix mineralization. J Bone Miner Res. 2004; 20(1):81-7. DOI: 10.1359/JBMR.041026. View

Milano A, Pendergrass S, Sargent J, George L, McCalmont T, Connolly M . Molecular subsets in the gene expression signatures of scleroderma skin. PLoS One. 2008; 3(7):e2696. PMC: 2481301. DOI: 10.1371/journal.pone.0002696. View

10.

Yeowell H, Walker L, Mauger D, Seth P, Garcia-Blanco M . TIA nuclear proteins regulate the alternate splicing of lysyl hydroxylase 2. J Invest Dermatol. 2008; 129(6):1402-11. DOI: 10.1038/jid.2008.386. View

11.

Baraniak A, Lasda E, Wagner E, Garcia-Blanco M . A stem structure in fibroblast growth factor receptor 2 transcripts mediates cell-type-specific splicing by approximating intronic control elements. Mol Cell Biol. 2003; 23(24):9327-37. PMC: 309649. DOI: 10.1128/MCB.23.24.9327-9337.2003. View

12.

Yamamoto T . The bleomycin-induced scleroderma model: what have we learned for scleroderma pathogenesis?. Arch Dermatol Res. 2006; 297(8):333-44. DOI: 10.1007/s00403-005-0635-z. View

13.

Huh G, Hynes R . Regulation of alternative pre-mRNA splicing by a novel repeated hexanucleotide element. Genes Dev. 1994; 8(13):1561-74. DOI: 10.1101/gad.8.13.1561. View

14.

Higgins D, Thompson J, Gibson T . Using CLUSTAL for multiple sequence alignments. Methods Enzymol. 1996; 266:383-402. DOI: 10.1016/s0076-6879(96)66024-8. View

15.

van der Slot A, Zuurmond A, Bardoel A, Wijmenga C, Pruijs H, Sillence D . Identification of PLOD2 as telopeptide lysyl hydroxylase, an important enzyme in fibrosis. J Biol Chem. 2003; 278(42):40967-72. DOI: 10.1074/jbc.M307380200. View

16.

Sakkas L, Platsoucas C . Is systemic sclerosis an antigen-driven T cell disease?. Arthritis Rheum. 2004; 50(6):1721-33. DOI: 10.1002/art.20315. View

17.

Minovitsky S, Gee S, Schokrpur S, Dubchak I, Conboy J . The splicing regulatory element, UGCAUG, is phylogenetically and spatially conserved in introns that flank tissue-specific alternative exons. Nucleic Acids Res. 2005; 33(2):714-24. PMC: 548355. DOI: 10.1093/nar/gki210. View

18.

Whitfield M, Finlay D, Murray J, Troyanskaya O, Chi J, Pergamenschikov A . Systemic and cell type-specific gene expression patterns in scleroderma skin. Proc Natl Acad Sci U S A. 2003; 100(21):12319-24. PMC: 218756. DOI: 10.1073/pnas.1635114100. View

19.

van der Slot A, van Dura E, de Wit E, de Groot J, Huizinga T, Bank R . Elevated formation of pyridinoline cross-links by profibrotic cytokines is associated with enhanced lysyl hydroxylase 2b levels. Biochim Biophys Acta. 2005; 1741(1-2):95-102. DOI: 10.1016/j.bbadis.2004.09.009. View

20.

Brudno M, Gelfand M, Spengler S, Zorn M, Dubchak I, Conboy J . Computational analysis of candidate intron regulatory elements for tissue-specific alternative pre-mRNA splicing. Nucleic Acids Res. 2001; 29(11):2338-48. PMC: 55704. DOI: 10.1093/nar/29.11.2338. View